. 2022 Sep 8;14(18):3710. doi: 10.3390/nu14183710

Table 3.

Weights of organs of experimental groups (g).

Group	Liver	Kidney	Epididymal Fat Pad	Spleen	Thymus
NOR ⁽¹⁾	10.55 ± 0.33 ^(2),a,(3)	2.66 ± 0.08 ^NS,(4)	5.27 ± 0.287 ^a	0.72 ± 0.02 ^NS	1.61 ± 0.09 ^NS
LOP	9.90 ± 0.27 ^a,b	2.57 ± 0.08	5.29 ± 0.46 ^a	0.68 ± 0.01	1.67 ± 0.10
BIS	9.28 ± 0.32 ^b	2.51 ± 0.06	3.93 ± 0.26 ^b	0.70 ± 0.03	1.59 ± 0.06
SNZ-L	9.33 ± 0.24 ^b	2.58 ± 0.07	4.65 ± 0.29 ^a,b	0.70 ± 0.04	1.70 ± 0.09
SNZ-H	9.31 ± 0.37 ^b	2.45 ± 0.06	4.75 ± 0.51 ^a,b	0.74 ± 0.03	1.76 ± 0.06

⁽¹⁾ NOR: Normal group; LOP: Loperamide treated group; BIS: Loperamide and Bisacodyl 8 mg/kg treated group; SNZ-L: Loperamide and B. coagulans SNZ 1969 1 × 10⁸ CFU/day treated group; SNZ-H: Loperamide and B. coagulans SNZ 1969 1 × 10¹⁰ CFU/day treated group. ⁽²⁾ Mean ± SE (n = 8). ⁽³⁾ Means with different letters within each row are significantly different at p < 0.05 by Duncan’s multiple range test. ^{(4), NS}: Not significant.